Skip to main content

Lymphedema Clinical Trials

Review the lymphedema clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-16 of 16

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
Status: Active
Location: 2 locations
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Status: Active
Location: 2 locations
Photobiomodulation Therapy for the Treatment of Lymphedema in Head and Neck Cancer Survivors
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
ConMed HelixAR™ ElectroSurgical Generator With Argon Beam Coagulation Technology Study
Status: Active
Location: See ClinicalTrials.gov
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Status: Active
Location: See ClinicalTrials.gov
An Educational Training Program (LEF-SMP) for Promoting Self-Management in Head and Neck Cancer Survivors with Lymphedema and Fibrosis, PROMISE Trial
Status: Active
Location: 2 locations
Pravastatin, Pentoxifylline with Tocopherol, Ketoprofen and Pirfenidone for the Treatment or Prevention of Radiation Therapy Related Lymphedema and/or Fibrosis in Head and Neck Cancer Survivors, REVERSE-FIBROSE Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Photobiomodulation with Light-Emitting Diode Therapy for Improvement of Radiation Fibrosis Syndrome in Patients with Head and Neck Cancer, PBM-LEF Trial
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Mobile 3D Scan for Volumetric Measurement of the Head and Neck Region in Patients with Head and Neck Lymphedema
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Lymphovenous Bypass during Axillary Lymph Node Dissection or Inguinal Lymph Node Dissection for the Prevention of Lymphedema in Melanoma Patients
Status: Approved
Location: M D Anderson Cancer Center, Houston, Texas
Fluid Measurements and MRI in Determining Biomarkers of Lymphatic Dysfunction in Patients with Breast Cancer
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Objective Assessment of Outcomes following Immediate Lymphatic Reconstruction / LYMPHA
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Arm Measurements, Bioelectric Impedance Analysis, and Collection of Breast Tissue in Studying Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection
Status: Active
Location: 7 locations
Quality of Life Assessment in Patients with Secondary Lymphedema Undergoing Surgery or Non-surgical Treatment
Status: Active
Location: 2 locations
Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Prospective Screening for Breast Cancer-related Lymphedema
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts